A Phase II Study of Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Cancer
[Protocol 12-139] |
Trippett, Tanya |
- Hepatobiliary
- Kidney Cancer
- Sarcomas
- Thyroid Cancer
|
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
[Protocol 11-183] |
Trippett, Tanya |
- Neuroblastoma
- Primary Bone
- Sarcomas
- Ewing's Sarcoma
- Soft Tissue Sarcoma
|
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
[Protocol 11-210] |
Trippett, Tanya |
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
[Protocol 13-021] |
Trippett, Tanya |
- Pediatric Brain Tumors
- Primary Bone
- Sarcomas
- Solid Tumors
|
A Phase I Study of Plerixafor as a Chemosensitizing Agent for Children with Relapsed Acute Leukemia or Myelodysplastic Syndromes
[Protocol 11-208] |
Trippett, Tanya |
- Hematology
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
|
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast
[Protocol 13-023] |
Van Zee, Kimberly |
|
A Phase I Study of BMS-936558 in Combination with Sunitinib or Pazopanib in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147] |
Voss, Martin |
|
A Phase I Study of Axitinib plus Dalantercept for Patients with Metastatic Kidney Cancer
[Protocol 12-255] |
Voss, Martin |
|
A Phase II Trial of Vinorelbine and Cyclophosphamide with Bevacizumab or Temsirolimus in Patients with Recurrent/Refractory Rhabdomyosarcoma
[Protocol 11-026] |
Wexler, Leonard |
- Sarcomas
- Rhabdomyosarcoma
- Soft Tissue Sarcoma
|
A Phase I Study of Ipilimumab in Children, Adolescents, and Young Adults with Treatment-Refractory Cancer
[Protocol 10-193] |
Wexler, Leonard |
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
- Melanoma
- Sarcomas
|
A Phase II Study of Cixutumumab plus Temsirolimus in Children with Recurrent or Refractory Sarcoma
[Protocol 12-188] |
Wexler, Leonard |
- Primary Bone
- Sarcomas
- Osteosarcoma
- Soft Tissue Sarcoma
|
A Phase I Study of the NY-ESO-1 Vaccine plus Ipilimumab in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-253] |
Wolchok, Jedd |
|
A Phase Ib Study of MDX-1106 (BMS-936558) in Combination with Ipilimumab (BMS-734016) in Patients with Unresectable Stage III or Stage IV Malignant Melanoma
[Protocol 09-155] |
Wolchok, Jedd |
|
A Study of the Biologic Effects of BMS-936558 in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-231] |
Wolchok, Jedd |
|
Heart-Sparing Whole Lung IMRT in Children and Young Adults with Lung Metastases: A Feasibility Study
[Protocol 11-100] |
Wolden, Suzanne |
- Primary Bone
- Sarcomas
- Ewing's Sarcoma
- Rhabdomyosarcoma
|
A Phase II Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094] |
Wu, Abraham |
|
A Pilot Study of Vemurafenib and Panitumumab in Patients with BRAF V600E-Mutated Metastatic Colorectal Cancer
[Protocol 12-221] |
Yaeger, Rona |
|
A Pilot Study of Image-Guided Navigation for High-Dose Rate Brachytherapy to Manage Discomfort in Patients with Previously Treated Spine Tumors
[Protocol 12-260] |
Yamada, Yoshiya |
|
A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
[Protocol 13-045] |
Younes, Anas |
|
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229] |
Young, James |
|
